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Abstract: A prospective hospital-based sentinel study conducted in Rio de Janeiro identified a shift in the pattern (long to 
short electropherotype and P(8) to P(4) genotype) of rotavirus strains recovered from children with severe diarrhea a few 
months after the far-reaching Brazilian rotavirus immunization program was launched, posing new interesting challenges. 
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INTRODUCTION 
  Group A rotavirus infection is an important cause of pe-
diatric hospitalization due to severe diarrhea and a global 
public health concern. Rotaviruses possess a genome of 11 
segments of double-stranded RNA that may undergo natural 
reassortment during mixed infections [1]. According to the 
composition of the genomic ensemble, rotavirus strains are 
classified into genogroups [2]. One major (Wa-like) and two 
minor (DS1- and AU1-like) genogroups have been described 
for human strains, with those of Wa and AU1 genogroups 
usually associated with long electropherotypes and those of 
DS1 genogroup with short ones. Rotavirus genomic seg-
ments 4 and 9 code for the outer capsid VP4 (P) and VP7 
(G) proteins, respectively, which independently determine 
the virus serotypes [3]. Although immunity against rotavirus 
infection is still poorly understood, protection against severe 
diarrheal disease is believed to be serotype-specific, and vac-
cines targeting some of the most common human rotavirus 
serotypes, G1, G2, G3, G4 and P(8), have been developed by 
two different approaches [4]. One was based on the produc-
tion of several animal-human monoreassortants containing 
the desired human gene 9 or 4 segment and the animal ge-
nomic backbone; the other was based on the classical at-
tenuation of a rotavirus strain. In August 1998, the tetrava-
lent rhesus-human reassortant rotavirus vaccine, RRV-TV, 
Rotashield
® (Wyeth Laboratories, USA) was licensed in the 
United States and included in the immunization schedule for 
infants. After one year however, rotavirus immunizations 
were suspended and the vaccine was withdrawn from the 
market due to its association with intussusception in vacci-
nated recipients [5, 6]. Seven years later, in August 2005, an 
oral live attenuated human G1P(8) rotavirus vaccine, Ro-
tarix
® (GlaxoSmithKline, Belgium) was licensed for private  
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pediatric use in Brazil and by March 2006, it was incorpo-
rated into the National Childhood Immunization Program 
assuring free vaccination to all 2-month old infants in the 
country [7, 8]. 
  Rotavirus vaccines aim at preventing infant deaths and 
hospitalizations due to severe diarrhea. Thus, prospective 
hospital-based studies on rotavirus-associated hospitaliza-
tions are critical to assess changes related to immunization 
programs. Anticipating vaccine introduction, a sentinel study 
was established at the Emergency Service of our university 
children’s hospital to investigate the burden of acute child-
hood gastroenteritis and to gather information on rotavirus 
strains before and after vaccine introduction. Here we report 
the results on the rotavirus strains causing the most severe 
diarrheal cases that required at least an overnight hospital 
stay for intravenous rehydration therapy. 
MATERIALS AND METHODS 
  The Instituto de Puericultura e Pediatria Martagão Geste-
ira (IPPMG/UFRJ) serves a low socioeconomic population 
living in nearby crowded communities adjacent to the uni-
versity campus in Rio de Janeiro. The study was approved 
by the hospital Ethical Committee (Proc#08/2002) and fecal 
specimens, clinical and epidemiological data were collected 
after written informed consent from the child’s parent or 
guardian. Total RNA was purified from fecal specimens by 
adsorption and elution from hydroxyapatite [9] and screened 
for rotavirus genomic segments by polyacrylamide gel elec-
trophoresis (PAGE) [10] and by reverse transcription-PCR 
(RT-PCR) followed by nested PCR with pools of G and P 
type-specific primers [11, 12]. Typing results were con-
firmed in a dot hybridization assay [13]. 
RESULTS 
  From August 2002 to December 2006, rotavirus was de-
tected in 97 (50%) out of 193 specimens (Table 1). One 
strain showed an atypical profile and was confirmed as a   
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Table 1.  G and P Genotypes and Electropherotypes of the 97 
Rotavirus Positive Samples Out of 193 Specimens 
from Children Hospitalized at IPPMG from August 
2002 to December 2006. 
 
No. of Specimens 
 
Genotype  E-Type
a 
2002  2003 2004 2005  2006 Total 
G1P(8)  L1  4  3   6   -  -  13 
G1P(6) nd  -  1    -  -  -  1 
G1P(4) nd  -  1    -  -  -  1 
G2P(4)  S1, S3  2   -  -  -  4   6 
G3P(9) L3  1  *  - - - -  1 
G9P(8) L6  -  4    11    24   3   42 
G9P(6)  L10  -  -  1   1   -  2 
G9P(4) S2  1  *  - - - 6   7 
G1G2P(8)  L1  - -  3*  - -  3 
G1G4P(8)  L1  - - 3 - -  3 
G1G9P(8)  L1  1  3   -  -  2   6 
G1G9P(4) L8  -  2    -  -  -  2 
G2G10P(4)  S4  - - - - 1   1 
G4G9P(8)  L4  1    - - - -  1 
G1G4G9P(8) L6  -  -  1  *  - -  1 
G1P(8)P(6) L2  1  *  - - - -  1 
G9P(8)P(4) L5  1  *  - - - -  1 
G9P(8)P(6)  L6  - - - 2    -  2 
G1G4P(8)P(6)  L9  - - 1    - -  1 
G1G9P(8)P(4) L1  -  1  *  - - -  1 
Total Rotavirus: 
Group A  
 
12 
 
15 
 
26 
 
27 
 
16 
 
96 
Group C   L7  -  1   -  -  -  1 
Distinct E-types (N)  (7)  (4)  (4)  (2)  (5)  (14) 
Mixed infections 
(%)  
6 
(50) 
6 
(40) 
8 
(31) 
2 
(7) 
3 
(19) 
25 
(26) 
Specimens analyzed 
(% Rotavirus positive rate) 
14 
(86) 
25 
(64) 
46 
(56) 
79 
(34) 
29 
(55) 
193 
(50) 
aElectropherotypes L: long, S: short, and nd: not defined. 
*One sample in the group presented the designated electropherotype plus one or more 
extra bands. 
 
group C rotavirus by RT-PCR [9]. An electropherotype was 
discernible in 88 (92%) specimens and eight were identified 
only by the more sensitive genotyping assay (Figs. 1,2). 
Mixed infections were revealed in 23 (24%) specimens by 
genotyping, and in seven (7%) by PAGE including two 
specimens in which only a single GP combination was de-
tected thus, raising to 25 (26%) the total number of mixed 
infections observed. Major electropherotypes, such as L1 or 
L6, were recognizable in some mixtures despite the presence 
of additional bands, but other specimens that contained mul-
tiple rotavirus strains (multiple G or P types) presented 
unique electropherotypes without extra bands [14]. The vast 
majority (92%) of the specimens contained G1 or G9 strains, 
or both, although there was a considerable year to year strain 
variation. Rotavirus G1P(8) profile L1 was detected in 27% 
of the specimens, either singly or with other rotavirus strains, 
during all years except 2005 when an emerging G9P(8) pro-
file L6 strain overran other strains and accounted for practi-
cally all confirmed rotavirus-related hospitalizations of that 
year. Overall, genotype G9 was detected in 66% and P(8) in 
72% of the rotavirus infections. Types G1 and G9 were also 
found in combination with P(6) and P(4), either in single or 
multiple infections; G4 was found only in mixtures and 
mostly in 2004; G2 was found sporadically and presented 
short electropherotypes when combined with P(4); and a rare 
G3P(9) was detected in 2002. The two major P(8) strains 
(long profiles L1 and L6) were also seen in the summer of 
2006, but only conspicuous short profiles were detected after 
April 2006. Those emerging strains of short profiles were 
typed as G2P(4), G9P(4) and G2G10P(4). 
 
Fig. (1). PAGE of group A rotavirus 10 dsRNA genome with the 
typical tight triplet formed by segments 7, 8 and 9. Electrophero-
types: L1 (A), L4 (B), L9 (C), L10 (D), L8 (E), and S1 (F). 
 
 
Fig. (2). PAGE of rotaviruses showing the same long electrophero-
type L6 found in specimens from 2003 (A), 2004 (B-C), 2005 (D-J) 
and 2006 (K), and the distinct short patterns S3 (L), S2 (M-N), S4 
(O) and S1 (P) obtained in 2006. 
  Considerable variation was also observed in the temporal 
distribution of rotavirus strains. Although this one-site sur-Changing Epidemiology of Rotavirus-Related Hospitalizations  The Open Virology Journal, 2007, Volume 1    49 
veillance study covered only the last semester of 2002, it 
showed a great variety of strains and a very high rotavirus 
detection rate concentrated in August, the first month of the 
study and mid winter in Rio de Janeiro. The following two 
years, 2003-2004, showed a marked decrease in strain diver-
sity, a tendency that was confirmed in the very unusual year 
of 2005 when a single strain predominated (Table 1, Fig. 2). 
In this atypical year, an overall marked drop in rotavirus 
detection rate was observed among hospitalized children and 
most of the rotavirus-associated cases occurred earlier, in the 
spring months of March and May. Temporal displacement of 
rotavirus activity occurred again in 2006, when strains L1 
and L6 were detected in the summer months of January-
March. Only P(4) strains of short profiles were detected spo-
radically thereafter and the expected winter peak of rotavirus 
activity was not observed. 
  The majority (88%) of the rotavirus-associated cases 
comprised infants and children less than two years of age 
with the 6-12 month-old group being the most affected (Ta-
ble 2). These results are in agreement with the highest inci-
dence of dehydrating disease recorded in developing coun-
tries [8, 14] and with the recommendation for rotavirus im-
munization of infants at the early age of 6-14 weeks old [14, 
15]. 
Table  2.  Age Distribution of the Group A Rotavirus-Associ-
ated Diarrheal Cases Hospitalized from August 2002 
to December 2006 
 
No. of Cases Per Year  Age 
(Months)  2002
a  2003  2004  2005  2006  Total  (%) 
<  6  1 2 3 7 5 18  (19) 
6 - 12  6  10  15  12  6  49  (51) 
13 - 24  2  2  6  5  2  17  (18) 
25 - 60  2  1  2  3  1  9  (9) 
61 - 120  1  0  0  0  2  3  (3) 
aSpecimen collection started in August. 
 
DISCUSSION 
  Great diversity and complex mixtures of strains were 
described as hallmarks of the epidemiology of rotavirus in-
fections in southern Brazil where rotavirus infections occur 
year round with unpredictable peaks of activity [1, 14, 16, 
17]. This study showed those features and identified interest-
ing changes in the epidemiology of rotavirus strains causing 
the most severe diarrheal cases over a period of four and a 
half years. In spite of the modest number of specimens avail-
able in a single-site study dealing only with hospitalized 
cases, our study captured the general trend observed in simi-
lar studies conducted in three other public hospitals in the 
city during 1996-1998 and 2004 [17, 18]. Those studies re-
ported a great diversity of strains among hospitalized chil-
dren with diarrhea before 2002 and an overwhelming pre-
dominance of G1P(8) and G9P(8) in 2004, similar to the 
findings reported here. The tendency of a major single epi-
demic strain to overpower local strains was demonstrated by 
the predominance of G9P(8) profile L6 strain among the 
IPPMG-hospitalized children during 2005, as had been pre-
viously observed with another G9 strain (HFF16-like) 
among the most severe diarrheal cases treated at Hospital 
Fernando Figueira, Rio de Janeiro, during 1998 [13]. Chang-
ing in rotavirus epidemiology toward a predominance of G9 
strains is a worldwide phenomenon extensively reported by 
many authors and incorporation of G9 as a fifth G compo-
nent in future polyvalent vaccines is under consideration 
[19]. The sudden shift towards strains displaying short pro-
files and P(4) specificity observed in May 2006 seems to 
signal the local emergence of antigenically and genetically 
unrelated strains, most likely of the DS1 genogroup
i. Indeed, 
other recent studies conducted at the Salles Netto Municipal 
Hospital in Rio de Janeiro
ii and in the midlands of Minas 
Gerais
iii, also reported detecting short profile G2P(4) strains 
at increasing frequency among hospital-assisted children 
with diarrhea during 2006 and beginning of 2007. Similar 
shift from predominantly long to short rotavirus electro-
pherotypes had been observed previously in Paraguay, a 
neighbor country where rotavirus vaccine has yet to be in-
troduced
iv. Taken together, those independent studies seem 
to confirm the proposed trend observed at our sentinel hospi-
tal by mid 2006. Whether those changes represent a new 
trend on rotavirus strains circulating in the South American 
cone region or they portend a new global trend dictated by 
the unpredictable fluctuation of rotavirus strains everywhere, 
must await reports from other continents [15]. Emergence of 
strains of the third, AU1 genogroup, is a possibility, given 
the presence of similar strains (G3P(9), profile L3) in the 
region. 
  Although no clear link between the introduction of the 
G1P(8) vaccine and a shift in rotavirus genotypes could be 
established, the observed changes coincided with the imple-
mentation of the rotavirus immunization program in Brazil 
and might reflect, at least in part, an immediate response to 
the extensive, virtually mandatory and year-long vaccination 
of infants with an attenuated strain of the Wa genogroup. 
Large clinical trials of the Rotarix
® vaccine performed in 
eleven Latin American countries showed high levels of pro-
tection not only against homotypic G1P(8) strains (91% vac-
cine efficacy) but also against strains sharing the P(8) speci-
ficity (and probably several other proteins as well) combined 
with either G3, G4, or G9 serotype (87% efficacy) [7, 8]. 
The vaccine conferred only low protection (42% efficacy) 
against rotavirus G2P(4) strains that do not share G or P epi-
topes with the vaccine strain [8]. Thus, one would expect the 
vaccine program to induce an early sharp decrease in the 
number of rotavirus-associated hospitalizations, leaving only 
a reduced number of severe cases associated to otherwise 
minor endemic or emerging strains of the non-Wa 
genogroup. This was the 2006 scenario observed in the pre-
sent sentinel study, as the short P(4) rotavirus strains did not 
produced major outbreaks or an accentuated epidemic sea-
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son, but rather, appeared to represent highlighted back-
ground. However, this situation might change drastically in 
the following years along with the changing rotavirus ecol-
ogy and an ever growing population of vaccinated Brazilian 
children. This unique situation poses a great opportunity to 
evaluate vaccine performance facing rotavirus infections 
with strains of distinct genotypes and distinct genogroups, to 
examine the contribution of rotavirus genes other than the 
VP4- and VP7-encoding genes to rotavirus immunity or sus-
ceptibility to severe diarrheal disease, as well as to assess the 
duration of vaccine protection. This single-site four and a 
half-year study included the first nine months of the far-
reaching Brazilian rotavirus immunization program, stressed 
the dynamic nature of rotavirus infections in the city, and 
further demonstrated the usefulness of electropherotyping to 
perceive new trends in rotavirus epidemiology. 
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